CCSB (1762.TW) monthly revenue, September 2026
CCSB reported revenue of NT$0.07bn for September 2026, up 17.0% from the previous month and up 90.5% from a year earlier. Year-to-date revenue was NT$0.88bn, up 27.9% year on year. It ranked 11 of 159 companies in the Biotechnology and Medical Care industry by year-on-year growth.
| Month | Revenue NT$bn | MoM % | YoY % |
|---|---|---|---|
| September 2026 | 0.07 | 17.0 | 90.5 |